Regencell Bioscience Stock Rallies 17.87% on Cooling January Inflation
Regencell Bioscience shares jumped 17.87% in premarket trading on February 13 after January’s consumer-price inflation slowed to a 2.4% annual rate, the lowest since May 2025. Core CPI also dipped to 2.5% year-over-year while monthly headline CPI rose 0.2%, fueling growth-stock rallies.
1. January Inflation Data
The Consumer Price Index increased 0.2% in January, bringing the annual inflation rate down to 2.4%, the weakest reading since May 2025. Core inflation, excluding food and energy, rose 0.3% monthly and eased to 2.5% year-over-year, signaling further deceleration in price pressures.
2. Market Reaction
Growth-sensitive equities rallied as investors priced in a higher likelihood of Federal Reserve rate cuts later this year. Major premarket movers included Rivian Automotive, Coinbase Global and Regencell Bioscience, reflecting a broad risk-on shift following the cooler inflation print.
3. Impact on Regencell Bioscience
Regencell Bioscience shares soared 17.87% in early trading, marking the stock’s largest one-day gain in over a year. The jump underscores investor appetite for high-growth biotech names amid expectations of lower borrowing costs.